-+ 0.00%
-+ 0.00%
-+ 0.00%

Inhibrx Biosciences to Present Phase 1 Ozekibart Combination Data at ESMO Sarcoma and Rare Cancers Congress

Reuters·03/02/2026 21:00:30

Please log in to view news